Starlink’s next-generation capacity narrative remains tied to Starship’s test cadence Thursday even when Flight 14 afterglow fades from headlines. Aviation altimeter and astronomy interference debates continue in parallel regulatory tracks.

Backstory: LEO broadband is now geopolitically strategic. Watch FCC filings and SpaceX launch cadence. Agree capacity is rising; differ on externalities.

As of Thursday, October 1, the public record on “Starlink capacity story continues after Starship test cadence” still matches the facts above. Tech coverage explains the product, launch, or policy fight and why the platform or agency move matters now. Reporting from SpaceX, Reuters anchors the Sources list; this card does not invent tallies, quotes, or outcomes beyond what those links support.

For a reader new to the thread: SpaceX’s constellation upgrades still track Starship progress. Aviation and astronomy stakeholders keep pressing interference concerns. SpaceX and Reuters coverage agree Starlink growth remains linked to launch cadence and regulatory fights. A short history beat matters here — prior seasons, rulings, product cycles, or diplomatic rounds set up today’s stakes — so the same-day news sits in context without filler. When the story is still moving, the copy states what is locked and what remains unsettled.

Where coverage lines up, SpaceX and Reuters coverage agree Starlink growth remains linked to launch cadence and regulatory fights. Where accounts still diverge, Rural users cheer coverage; astronomers and some airlines seek stricter limits. Putting the shared facts and the plain-language split side by side lets readers judge the next development for themselves.

Company blogs, SpaceX and NASA launch pages, CISA advisories, and SEC filings beat screenshot rumors. If a timed hearing, print, game, or court deadline is attached, later updates should wait for confirmation from at least two independent outlets before treating an outcome as final. Until then, treat this wording as the careful Thursday morning baseline, not a prediction.